Gilead Wins Approval for a Single HIV Tablet Aimed at Patients Taking Handfuls of Pills Each Day

FDA approved Bixlenvo, a once-daily tablet combining bictegravir and lenacapavir for virologically suppressed adults on complex HIV regimens.


View article...


Top stories of the last 30 days